Search Results1-17 of  17

  • Saji Shigehira ID: 9000390405162

    Articles in CiNii:1

    • Regional differences in advanced gastric cancer : exploratory analyses of the AVAGAST placebo arm (2018)
  • SAJI Shigehira ID: 9000002281165

    Articles in CiNii:169

    • Modulation of transcription activity of estrogen receptor by wild-type p53 involving MDM2 (1998)
    • Role of MDM2 in Estrogen receptor bearing breast cancer cells (1998)
    • New Optically Active 4,4-Dialky1-γ-lactones as Chiral Dopants for Ferroelectric Liquid Crystals (1992)
  • SAJI Shigehira ID: 9000019138520

    Department of Target Therapy Oncology, Kyoto University Graduate School of Medicine (2012 from CiNii)

    Articles in CiNii:1

    • Trends in local therapy application for early breast cancer patients in the Japanese Breast Cancer Society Breast Cancer Registry during 2004-2009 (2012)
  • SAJI Shigehira ID: 9000019241565

    Department of Target Therapy Oncology, Kyoto University, Graduate School of Medicine (2012 from CiNii)

    Articles in CiNii:1

    • Possible available treatment option for early stage, small, node-negative, and HER2-overexpressing breast cancer (2012)
  • SAJI Shigehira ID: 9000252855243

    Department of Surgery, Sumi Hospital (1999 from CiNii)

    Articles in CiNii:1

    • A CASE OF TRAUMATIC HERNIA OF THE RIGHT DIAPHRAGM SUCCESSFULLY DIAGNOSED BY MAGNETIC RESONANCE IMAGING (MRI) (1999)
  • SAJI Shigehira ID: 9000257891918

    Department of Medical Oncology, International Medical Center-Comprehensive Cancer Center, Saitama Medical University (2012 from CiNii)

    Articles in CiNii:1

    • Association of <i>ABCC2</i> Genotype with Efficacy of First-line FOLFIRI in Japanese Patients with Advanced Colorectal Cancer (2012)
  • SAJI Shigehira ID: 9000365521336

    Articles in CiNii:1

    • Distinct promoter usage of mdm2 gene in human breast cancer (2002)
  • Saji Shigehira ID: 9000024028374

    Articles in CiNii:1

    • Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery (2011)
  • Saji Shigehira ID: 9000258576787

    International Medical Center-Comprehensive Cancer Center, Saitama Medical University (2010 from CiNii)

    Articles in CiNii:1

    • THE SMALL-MOLECULE TYROSINE KINASE INHIBITOR NILOTINIB IS A POTENT NONCOMPETITIVE INHIBITOR OF THE SN-38 GLUCURONIDATION BY HUMAN UGT1A1 (2010)
  • Saji Shigehira ID: 9000258577355

    Department of Medical Oncology, International Medical Center-Comprehensive Cancer Center, Saitama Medical University (2010 from CiNii)

    Articles in CiNii:1

    • SEVERE RENAL FAILURE REQUIRING DIALYSIS CAUSES DELAYED ELIMINATION OF SN-38 IN CANCER PATIENTS WHO RECEIVE IRINOTECAN (2010)
  • Saji Shigehira ID: 9000270141201

    Articles in CiNii:1

    • Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure (2014)
  • Saji Shigehira ID: 9000298901146

    Articles in CiNii:1

    • Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer. (2013)
  • Saji Shigehira ID: 9000344802920

    Articles in CiNii:1

    • Circulating cell-free DNA-based epigenetic assay can detect early breast cancer (2016)
  • Saji Shigehira ID: 9000344802923

    Articles in CiNii:1

    • Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy (2016)
  • Saji Shigehira ID: 9000399372387

    Department of Medical Oncology, Fukushima Medical University (2018 from CiNii)

    Articles in CiNii:1

    • Development of a prognostic nomogram for metastatic colorectal cancer patients: The study protocol of a multicenter, retrospective, observational, cohort study (2018)
  • Saji Shigehira ID: 9000404539581

    Depertment of Medical Oncology, Fukushima Medical University (2019 from CiNii)

    Articles in CiNii:1

    • CDK4/6 inhibitor (2019)
  • Shigehira Saji ID: 9000400187700

    Articles in CiNii:1

    • Neoadjuvant endocrine therapy with exemestane followed by response-guided combination therapy with low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study (2018)
Page Top